Randomized Study Evaluating the Treatment of Vulvovaginal Gaping by Plication of the Puborectalis Muscles Versus Perineorrhaphy ± Transverse Myorrhaphy of the Puborectalis Muscles at 12 Months. (HERA)
HERA
1 other identifier
interventional
100
1 country
1
Brief Summary
Vulvovaginal incompetence is generally associated with prolapse and contributes to the pathogenesis of the latter. The perineum and the perineal body (PB) are structures frequently injured throughout life, leading to vesicourethral and rectoanal dysfunction, which are the main focus of study. Other symptoms, such as periorificial dyspareunia and vulvovaginal incompetence, appear to be less verbalized by women. The resulting sexual discomfort is linked, on the one hand, to physical anatomical trauma, with, in some cases, vulvovaginal incompetence contributing to a vaginal sensitivity decreased, and, on the other hand, to psychological trauma with damage to self-image. Vulvoperineoplasty is a surgical repair procedure that aims to optimally reconstruct the introital anatomy by correcting the vulvovaginal incompetence in order to restore normal anatomy, restore self-image, and treat the symptoms of vaginal laxity (feeling of a vagina that is too large and loss of vaginal sensitivity). Conventional surgical techniques for treating vulvar incompetence, such as levator myorrhaphy and perineorrhaphy, are currently being questioned because they cause functional sequelae, particularly regarding to sexual quality of life. The pubo-rectal muscle plication (PPR) technique is based on the anatomical observation of puborectalis muscle lengthening (PMR) observed on MRI scans in patients with vaginal incompetence. This technique could be an interesting alternative in the surgical treatment of vulvovaginal incompetence. The main objective of this study is to evaluate the effectiveness of anatomical reconstruction of vulvovaginal incompetence by sagittal plication of the puborectalis muscles vs. by perineorrhaphy ± transverse myorrhaphy of the puborectalis muscles at 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedStudy Start
First participant enrolled
November 20, 2025
CompletedFirst Posted
Study publicly available on registry
November 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 25, 2029
November 24, 2025
November 1, 2025
3.4 years
November 17, 2025
November 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Effectiveness of anatomical reconstruction of vulvovaginal gaping
The effectiveness of anatomical reconstruction of the vulvovaginal gap will be assessed at 12 months using a composite criterion. The reconstruction will be considered successful if the following three criteria are met: * Resting GH \< 4 cm, * AND PGI-I "overall condition" improved or greatly improved, * AND pain during intercourse rated "never or rarely" (question 6 of the PPSSQ)
12 months
Study Arms (2)
Sagittal plication of the puborectal muscles reconstruction
EXPERIMENTALAnatomical reconstruction of the vulvovaginal gape by sagittal plication of the puborectal muscles
Perineorrhaphy ± transverse myorrhaphy of the puborectal muscles reconstruction
ACTIVE COMPARATORAnatomical reconstruction of the vulvovaginal gape by perineorrhaphy ± transverse myorrhaphy of the puborectal muscles
Interventions
Anatomical reconstruction of the vulvovaginal gape with two different surgeries
Questionnaires of quality of sexual life (PPSSQ), of anal incontinence and constipation
MRI of the genital hiatus
Eligibility Criteria
You may qualify if:
- Female patient between 18 and 80 years-old.
- Genital hiatus at rest ≥ 4 cm by POP-Q
- Sexually active woman without pain (never/rarely scored) during penetration and who has stopped sexual activity due to vulvovaginal incompetence without pain (never/rarely scored) during penetration
- Prolapse
- Candidate for surgery for anatomical reconstruction of the vulvovaginal incompetence
- Patient affiliated with a social security scheme or beneficiary of such a scheme, according to Article L.1124-1 of the Public Health Code
- Free, informed and signed consent
You may not qualify if:
- Resting GH \< 4 cm (POP-Q classification)
- Women not sexually active and not planning to become sexually active
- Chronic perineal pain syndrome
- Anal sphincter injury with concomitant indication for sphincterorrhaphy
- Cognitive or language impairment of the patient unable to complete the study questionnaires
- Contraindications to surgery or anesthesia
- Adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative decision, hospitalized without consent
- Pregnant, breastfeeding, or parturient woman
- Patient planning to become pregnant during the study period
- Immediate postpartum
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital privé Dijon Bourgogne
Dijon, 21000, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2025
First Posted
November 24, 2025
Study Start
November 20, 2025
Primary Completion (Estimated)
April 20, 2029
Study Completion (Estimated)
April 25, 2029
Last Updated
November 24, 2025
Record last verified: 2025-11